Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

The role of [18F]fluorodopa positron emission tomography in grading of gliomas

ROACH JOY. et al, (2022), Journal of Neuro-Oncology

A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.

Jones R. et al, (2022), Clin Cancer Res

A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.

Curigliano G. et al, (2022), Br J Cancer

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.

Robbe P. et al, (2022), Nat Genet

A rare HIV-associated hyaline vascular multicentric castleman disease with good early response to single-agent rituximab: A case from Tanzania

Mawalla WF. et al, (2022), Human Pathology Reports, 30

Total pelvic exenteration surgery for loco-regionally advanced prostate cancer, is it justifiable?

Cussenot O. et al, (2022), BJU International, 130, 582 - 585

ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressiveness.

Koyasu S. et al, (2022), EMBO reports

A new phosphoramidite enables orthogonal double labelling to form combination oligonucleotide probes.

Bai C. et al, (2022), Org Biomol Chem

Ferroptosis, a key to unravel the enigma of the FLASH effect?

Vilaplana-Lopera N. et al, (2022), Br J Radiol

CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial.

Saunders MP. et al, (2022), ESMO Open, 7

How the histological structure of some lung cancers shaped almost 70 years of radiobiology

Worth K. et al, (2022), British Journal of Cancer

ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma.

Klasson TD. et al, (2022), Cancer Metab, 10

First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors.

Davis EJ. et al, (2022), J Immunother Cancer, 10

Solute exchange through gap junctions lessens the adverse effects of inactivating mutations in metabolite-handling genes.

Monterisi S. et al, (2022), Elife, 11

Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains

Sekirnik AR. et al, (2022), ACS Chemical Biology

A fluorescent probe strategy for the detection and discrimination of hydrogen peroxide and peroxynitrite in cells.

Bolland HR. et al, (2022), Chem Commun (Camb)

Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT.

Kim RY. et al, (2022), Radiology, 304, 683 - 691

Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy

Krieg C. et al, (2022), Journal for ImmunoTherapy of Cancer, 10, e004717 - e004717

Obesity: a perfect storm for carcinogenesis.

Harris BHL. et al, (2022), Cancer Metastasis Rev

How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?

Horgan D. et al, (2022), Healthcare (Basel), 10

Load More

1
2
3
4
5
6
7
...
»